PORTOLA PHARMACEUTICALS INC's ticker is and the CUSIP is 737010908. A total of 5 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,014,000 | +91.7% | 564 | -24.0% | 0.00% | +100.0% |
| Q1 2020 | $529,000 | -74.6% | 742 | -15.0% | 0.00% | -80.0% |
| Q4 2019 | $2,084,000 | +176.8% | 873 | +210.7% | 0.01% | +150.0% |
| Q3 2019 | $753,000 | +95.6% | 281 | +97.9% | 0.00% | +100.0% |
| Q2 2019 | $385,000 | -35.4% | 142 | -17.4% | 0.00% | -50.0% |
| Q1 2019 | $596,000 | -67.5% | 172 | -81.7% | 0.00% | -60.0% |
| Q4 2018 | $1,836,000 | +63.8% | 941 | +123.5% | 0.01% | +25.0% |
| Q3 2018 | $1,121,000 | +36.2% | 421 | +93.1% | 0.00% | +33.3% |
| Q2 2018 | $823,000 | +14.5% | 218 | -99.0% | 0.00% | -90.6% |
| Q1 2018 | $719,000 | +641.2% | 21,731 | +8290.3% | 0.03% | +700.0% |
| Q4 2017 | $97,000 | +83.0% | 259 | +311.1% | 0.00% | +100.0% |
| Q3 2017 | $53,000 | -92.5% | 63 | -90.6% | 0.00% | -93.5% |
| Q2 2017 | $711,000 | +558.3% | 672 | +192.2% | 0.03% | +520.0% |
| Q1 2017 | $108,000 | +63.6% | 230 | -32.6% | 0.01% | +25.0% |
| Q4 2016 | $66,000 | +17.9% | 341 | +7.9% | 0.00% | 0.0% |
| Q3 2016 | $56,000 | – | 316 | +31500.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 1 | -98.2% | 0.00% | – |
| Q1 2016 | $1,000 | -92.3% | 57 | +119.2% | 0.00% | -100.0% |
| Q4 2015 | $13,000 | +333.3% | 26 | +225.0% | 0.00% | – |
| Q3 2015 | $3,000 | -40.0% | 8 | +14.3% | 0.00% | – |
| Q2 2015 | $5,000 | -28.6% | 7 | +40.0% | 0.00% | -100.0% |
| Q1 2015 | $7,000 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|